Tag: LCT

Living Cell Technologies ASX LCT NTCELL implantation Parkinson's trial patient data

Living Cell Technologies publishes encouraging follow up data for Parkinson’s drug NTCELL

Biotechnology company Living Cell Technologies (ASX: LCT) has published what could end up proving to be pivotal findings from an 18-month follow up of 18 patients in its existing Phase 2b study of NTC...
Living Cell Technologies ASX LCT Parkinson’s disease treatment NTCELL

Living Cell Technologies Parkinson’s disease treatment shows signs of efficacy in phase II study

Treating nervous system-related conditions could soon be taking a technology-induced futuristic turn after biotechnology developer Living Cell Technologies (ASX: LCT) confirmed the safety profile of i...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS